ANUHPHR · Anuh Pharma Limited · Financials
Market Cap
8.26B INR
Shares
100.22M
Volume · Nov 13
38.69K
Avg daily vol (3M)
156.21K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
7.72B
+16.7%
FY2026
Net Income
410.46M
-13.3%
FY2026
Operating Cash Flow
-30.12M
-108.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 7.78B | 7.72B | 6.62B |
| INR | 108.9M | 113.82M | 87.39M |
| INR | 2.41M | 4.72M | 6.19M |
| INR | 653.24M | 542.21M | 610.05M |
| INR | 175.53M | 131.75M | 136.53M |
| INR | 477.7M | 410.46M | 473.52M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 274.92M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.